Cocaine pharmacodynamics after intravenous and oral administration in rats: relation to pharmacokinetics

被引:34
作者
Ma, F [1 ]
Falk, JL [1 ]
Lau, CE [1 ]
机构
[1] Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA
关键词
absolute oral bioavailability; cocaine; benzoylecgonine; norcocaine; pharmacokinetics; pharmacodynamics;
D O I
10.1007/s002130051014
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: To design optimal dose regimes for oral cocaine, it is essential to characterize pharmacokinetics (PK) of cocaine after IV and PO administration. Objectives: To investigate the absolute bioavailability of oral cocaine, its effectiveness and the relation between PK and PD in a within-subject design. Methods: We used the effects of IV and PO cocaine on a contingency-controlled timing behavior, the differential reinforcement of low rate schedule (DRL 45-s) in 3-h sessions, as the PD measures [i.e., the shorter-response rate (srr) and the reinforcement rate (rr)]. Cocaine PK parameters were determined by simultaneous modeling of the concentration-time profiles (CTPs) after IV 2 mg/kg and PO 20 mg/kg cocaine administration. The absolute oral cocaine bioavailability was determined pharmacokinetically (F) and pharmacodynamically (F-srr and F-rr). Results: IV and PO cocaine increased the shorter response rate and decreased the reinforcement rate in a dose- and time-related fashion, which mirrored the respective prototypical serum cocaine CTPs. After the absorption phase, the serum cocaine CTP of PO cocaine paralleled that of IV cocaine. The duration of action for PO cocaine was longer than that for IV cocaine owing to its larger mean residence time. The active metabolite, norcocaine, was not detected after IV but after PO cocaine administration. The value of F was 4.66% which was significantly lower than the values of F-srr (13.67%) and F-rr (32.63%). Furthermore, the concentration-effect relations for the reinforcement rate revealed that PO cocaine was more potent than IV cocaine. Conclusions: Oral cocaine is more effective behaviorally than from predictions made in terms of its PK. The differences in active metabolite profiles as well as the rate and extent of acute tolerance for IV versus PO cocaine may account for the greater potency observed for oral cocaine.
引用
收藏
页码:323 / 332
页数:10
相关论文
共 46 条
  • [1] Allen CatherineJ., 1988, The Hold Life Has: Coca and Cultural Identity in an Andean Community
  • [2] COCAINE PHARMACOKINETICS IN HUMANS
    BARNETT, G
    HAWKS, R
    RESNICK, R
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 1981, 3 (2-3) : 353 - 366
  • [3] COMPARATIVE BEHAVIORAL PROFILE OF COCAINE AND NORCOCAINE IN RATS AND MONKEYS
    BEDFORD, JA
    BORNE, RF
    WILSON, MC
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1980, 13 (01) : 69 - 75
  • [4] BENUCK M, 1987, J PHARMACOL EXP THER, V243, P144
  • [5] BONI JP, 1991, J PHARMACOL EXP THER, V257, P307
  • [6] Dose-response cocaine pharmacokinetics and metabolite profile following intravenous administration and arterial sampling in unanesthetized, freely moving male rats
    Booze, RM
    Lehner, AF
    Wallace, DR
    Welch, MA
    Mactutus, CF
    [J]. NEUROTOXICOLOGY AND TERATOLOGY, 1997, 19 (01) : 7 - 15
  • [7] CORRELATION OF SALIVA COCAINE LEVELS WITH PLASMA-LEVELS AND WITH PHARMACOLOGIC EFFECTS AFTER INTRAVENOUS COCAINE ADMINISTRATION IN HUMAN-SUBJECTS
    CONE, EJ
    KUMOR, K
    THOMPSON, LK
    SHERER, M
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 1988, 12 (04) : 200 - 206
  • [8] ALPRAZOLAM - A REVIEW OF ITS PHARMACODYNAMIC PROPERTIES AND EFFICACY IN THE TREATMENT OF ANXIETY AND DEPRESSION
    DAWSON, GW
    JUE, SG
    BROGDEN, RN
    [J]. DRUGS, 1984, 27 (02) : 132 - 147
  • [9] COMPARISON OF ORAL AND SUBCUTANEOUS ROUTES OF COCAINE ADMINISTRATION ON BEHAVIOR, PLASMA DRUG CONCENTRATION AND TOXICITY IN FEMALE RATS
    DOWEDWARDS, D
    FICO, TA
    OSMAN, M
    GAMAGARIS, Z
    HUTCHINGS, DE
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 33 (01) : 167 - 173
  • [10] COMPARATIVE PHARMACOKINETICS AND PHARMACODYNAMICS OF LORAZEPAM, ALPRAZOLAM AND DIAZEPAM
    ELLINWOOD, EH
    HEATHERLY, DG
    NIKAIDO, AM
    BJORNSSON, TD
    KILTS, C
    [J]. PSYCHOPHARMACOLOGY, 1985, 86 (04) : 392 - 399